Renaissance Technologies LLC Acquires 182,900 Shares of Amedica Co. (AMDA)

Share on StockTwits

Renaissance Technologies LLC increased its holdings in shares of Amedica Co. (NASDAQ:AMDA) by 152.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 302,996 shares of the medical equipment provider’s stock after acquiring an additional 182,900 shares during the quarter. Renaissance Technologies LLC owned about 6.86% of Amedica worth $286,000 as of its most recent filing with the SEC.

NASDAQ:AMDA opened at $0.27 on Friday. Amedica Co. has a 52 week low of $0.18 and a 52 week high of $6.40. The stock has a market cap of $3.44 million, a P/E ratio of -0.09 and a beta of -1.24.

Amedica (NASDAQ:AMDA) last released its quarterly earnings results on Tuesday, August 14th. The medical equipment provider reported ($1.65) EPS for the quarter. Amedica had a negative return on equity of 148.60% and a negative net margin of 139.62%. The business had revenue of $2.04 million for the quarter. On average, analysts anticipate that Amedica Co. will post -2.93 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by Macon Daily and is owned by of Macon Daily. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at

About Amedica

Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers silicon nitride implants to surgeons and hospitals for use in cervical and thoracolumbar spine surgery under the Valeo brand.

See Also: Does the discount rate affect the economy?

Want to see what other hedge funds are holding AMDA? Visit to get the latest 13F filings and insider trades for Amedica Co. (NASDAQ:AMDA).

Receive News & Ratings for Amedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica and related companies with's FREE daily email newsletter.

Leave a Reply